Tafluposide

Star0

DB21110ExperimentalSmall molecule

Tafluposide is a small molecule drug. Tafluposide has a monoisotopic molecular weight of 1116.13 Da.

Formula / weight: C₄₅H₃₅F₁₀O₂₀P · 1116.713 g/mol (avg)
Code names: F-11782

Resolves to

Compound

UNIIQN043X3ZDWCAS179067-42-6ChEMBLCHEMBL3989413ChEBI756036PubChem9877073

Structure

InChIKeyRTJVUHUGTUDWRK-CSLCKUBZSA-NSMILES

[H][C@]12COC(=O)[C@]1([H])[C@H](C1=CC(OC)=C(OP(O)(O)=O)C(OC)=C1)C1=C(C=C3OCOC3=C1)[C@@]2([H])O[C@@H]1O[C@]2([H])CO[C@@H](C)O[C@@]2([H])[C@H](OC(=O)COC2=C(F)C(F)=C(F)C(F)=C2F)[C@H]1OC(=O)COC1=C(F)C(F)=C(F)C(F)=C1F

Targets

P11387TOP1P11388TOP2AQ02880TOP2B

What you can answer from here — as of September 23, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Tafluposide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account